Chemify is embarking on an £89.9m expansion in Glasgow that will increase research and manufacturing capacity, establish a new global headquarters and create up to 300 highly skilled jobs.
The digital chemistry company will receive £22m of public funding, comprising £16m from Scottish Enterprise and £6m from the UK Government. Chemify is contributing a further £67.9m, meaning private investment accounts for most of the overall expansion programme.
Founded in 2019 as a University of Glasgow spinout, Chemify combines robotics, software and artificial intelligence to automate the design, manufacture and testing of chemical compounds. Its technology is intended to reduce the time required to identify and physically produce molecules for pharmaceuticals, advanced materials and other chemistry-intensive markets.
The company will establish its global headquarters and research and development centre at the University of Glasgow’s Health Innovation Hub in Govan, within the Glasgow Riverside Innovation District. It will also expand automated manufacturing operations elsewhere in the city.
The programme is expected to increase Chemify’s Scottish workforce from 152 people to around 450 over three years, creating up to 300 jobs and safeguarding a further 100. Recruitment is expected to span chemistry, advanced manufacturing, robotics, software and life sciences.
Founder and chief executive Professor Lee Cronin said: “The additional funding will enable us to hyperscale chemistry, expand our next-generation Chemifarm and advance our Chemify Genesis system.”
The expansion provides a practical test of a long-standing challenge for the UK research economy: converting university science into companies that reach substantial commercial scale while retaining high-value operations domestically. Deep-technology spinouts frequently require more capital and physical infrastructure than software businesses, making the transition from research project to industrial company particularly demanding.
Chemify’s model also sits at the intersection of two investment trends. Pharmaceutical and materials companies are increasingly using machine learning to identify promising compounds, while laboratory automation is reducing the amount of repetitive work that needs to be performed manually. The commercial opportunity lies in connecting digital prediction with physical chemistry.
An algorithm can suggest a molecule, but the compound still has to be manufactured, tested and refined. That makes Chemify’s expansion partly an advanced-manufacturing project rather than simply another enterprise AI investment. Scaling laboratory robotics and automated chemical production requires specialist premises, engineering and capital equipment.
The funding structure is also notable. Public-sector support accounts for around a quarter of the total project value, with Chemify supplying the majority of capital. Scottish Enterprise and the UK Government are therefore using grant funding to support a larger private commitment while seeking to anchor the resulting jobs and intellectual property in Scotland.
That approach has become increasingly important as governments compete to retain technology businesses whose founders can access international capital. UK university spinouts routinely face choices over where to locate later-stage manufacturing, headquarters functions and research once they begin raising substantially larger funding rounds.
For Glasgow, an operation approaching 450 employees could also produce wider demand for specialist suppliers. Laboratory equipment, robotics, software, engineering, professional services and manufacturing support all sit around the core chemistry operation, creating opportunities beyond Chemify’s direct payroll.
The company describes its expanded infrastructure as a “Chemistry Hyperscaler”, borrowing terminology from computing. The comparison reflects its ambition to make automated chemistry available at much greater scale, although commercial performance will ultimately depend on whether customers can reduce discovery costs and development times using the system.
The immediate investment is more concrete: almost £90m directed towards facilities, research capability and automated manufacturing, with a planned near-tripling of the company’s Scottish workforce. If the expansion is delivered on schedule, Chemify will move from being a university spinout into a considerably larger industrial technology employer while keeping its principal growth programme in Glasgow.
You must be logged in to post a comment.